US Stock MarketDetailed Quotes

CHRO Channel Therapeutics

Watchlist
  • 0.644
  • -0.010-1.45%
Close Dec 20 16:00 ET
  • 0.620
  • -0.023-3.61%
Post 20:01 ET
3.88MMarket Cap-0.37P/E (TTM)

About Channel Therapeutics Company

Channel Therapeutics Corp. is a clinical-stage biotech company that engages in the development and commercialization of new therapeutics to alleviate pain. The company was founded in 2002 and is headquartered in Freehold, NJ.

Company Profile

SymbolCHRO
Company NameChannel Therapeutics
Listing DateFeb 16, 2024
Issue Price6.00
Founded2002
CEOMr. Francis Knuettel, II
MarketAMEX
Employees8
Fiscal Year Ends12-31
Address4400 Route 9 South,Suite 1000
CityFreehold
ProvinceNew Jersey
CountryUnited States of America
Zip Code07728
Phone1-877-265-8266

Company Executives

  • Name
  • Position
  • Salary
  • Francis Knuettel, II
  • Chief Executive Officer, Chief Financial Officer, Treasurer and Secretary
  • 307.01K
  • Dr. Eric Lang, PhD
  • Chief Medical Officer
  • 287.50K
  • Todd C. Davis
  • Chairman of the Board
  • 748.04K
  • Chia-Lin Simmons
  • Independent Director
  • 336.61K
  • Ezra M. Friedberg
  • Independent Director
  • 374.02K
  • Dr. Richard Malamut
  • Independent Director
  • 374.02K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.